Clinical Trials Sponsored by Apollomics Inc. (formerly CBT Pharmaceuticals, Inc.)

Total 4 results

Apollomics (Australia) Pty. Ltd.
Novotech (Australia) Pty Limited; Apollomics Inc. (formerly CBT Pharmaceuticals...

Completed

APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors

Solid Tumor | Microsatellite Instability | Mismatch Repair Deficiency | Cancer of Unknown Primary Site

Australia
Apollomics (Australia) Pty. Ltd.
Novotech (Australia) Pty Limited; Apollomics Inc. (formerly CBT Pharmaceuticals...

Terminated

APL-501 or Nivolumab in Combination With APL-101 in Locally Advanced or Metastatic HCC and RCC

Renal Cell Carcinoma | Hepatocellular Carcinoma

Australia, New Zealand
Chinook Therapeutics, Inc. (formerly Aduro)
Novartis Pharmaceuticals

Terminated

Safety and Efficacy of MIW815 (ADU-S100) +/- Ipilimumab in Patients With Advanced/Metastatic Solid Tumors or Lymphomas

Advanced/Metastatic Solid Tumors or Lymphomas

United States
BIO-CAT, Inc.
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Completed

Safety and Tolerability Trial of Microbial Inulinase

Gastrointestinal Health | Digestive Health

Canada

3

Subscribe